Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of MK-8342B vaginal ring versus levonorgestrel + ethinylestradiol oral contraceptive
NL-OMON42732Phase 3Active, not recruiting
- Sponsor
- Merck & Co.
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in contraception comparing MK-8342B vaginal ring with levonorgestrel + ethinylestradiol oral contraceptive (2 arms). Primary endpoint: Primary efficacy endpoint. Started Dec 2015; status: active, not recruiting.
02
Drugs
ENG-E2avatrombopagethinyl estradiol
03
Conditions
contraception
Beyond the preview
Go deeper on NL-OMON42732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42732.